Effects of Photobiomodulation on Postoperative Pain After Primary Endodontic Therapy in Molars With Symptomatic Apical Periodontitis

Not Applicable

Completed

• Conditions: Postoperative Pain
• Interventions: Device: PBM Therapy; Device: PBM Sham

• Registration Number: NCT05032612
• Lead Sponsor: The University of Texas Health Science Center, Houston

Brief Summary

The purpose of this study is to evaluate the effects of photobiomodulation (PBM) on postoperative pain after endodontic treatment in mandibular molar teeth diagnosed with symptomatic apical periodontitis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-08-26
• Study First Submitted QC: 2021-08-26
• Study First Posted: 2021-09-02
• Study Start: 2021-09-16
• Primary Completion: 2022-03-16
• Study Completion: 2022-03-16
• Status Verified: 2023-03
• Results First Submitted: 2023-03-01
• Results First Submitted QC: 2023-03-01
• Last Update Submitted: 2023-03-01
• Results First Posted: 2023-03-24
• Last Update Posted: 2023-03-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Posterior mandibular molars
• No previous root canal therapy on the tooth in question
• Able to complete the endodontic treatment in one visit

Exclusion Criteria

• Maxillary teeth, mandibular anteriors and premolars
• Infection (swelling, sinus tract) on the tooth in question
• Periodontal disease on the tooth in question
• Dental trauma
• Crown/ root fractures
• Systemic diseases
• Immunocompromised patients

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
PBM Therapy	PBM Therapy	-
PBM Sham	PBM Sham	-

Primary Outcome Measures

Name	Time	Method
Pain as Assessed by the Visual Analog Scale	72 hours after treatment	This scale ranges form 0(no pain) to 10(worst pain)

Secondary Outcome Measures

Name	Time	Method
Pain as Assessed by the Visual Analog Scale	0 hours, 6 hours, 12 hours and 24 hours hours after treatment	This scale ranges form 0(no pain) to 10(worst pain)

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston; 🇺🇸 Houston, Texas, United States